Lymphoma Drug Undergoing Trial Makes MS Relapses 5 Times Less Likely

A lymphoma drug undergoing a phase 3 clinical trial hopes to make multiple sclerosis relapses five times less likely.

from Medical Daily https://www.medicaldaily.com/lymphoma-drug-undergoing-trial-makes-ms-relapses-5-times-less-likely-466215?utm_source=Public&utm_medium=Feed&utm_campaign=Distribution

Comments

Popular posts from this blog

Inside Look: Medical School Clubs #medicalschool #premed #medicalstudent

Welcome home!